跳至主要内容
临床试验/ACTRN12611001216909
ACTRN12611001216909尚未招募不适用

Monitoring and comparing the effects of insulin therapy and a combination of insulin and metformin therapy on glucose control in patients at risk of developing type 2 diabetes

Rishaal Sharma0 个研究点目标入组 45 人开始时间: 2011年11月25日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention

入排标准

年龄范围
21 Years 至 o limit(—)
性别
All

入选标准

  • 21 years of age or older
  • Not specific to any gender or ethnic groups;
  • Persons with HbA1c between >= 5.7% and <6.5%;
  • Persons with impaired glucose tolerance or impaired fasting glucose levels

排除标准

  • Known diabetes (Fasting Plasma Glucose > 7.0 mmol/l; 2-hour 75-g OGTT plasma glucose > 11.1 mmol/l;
  • HbA1c result HbA1c<5.7% or > =6.5%;
  • Diabetes diagnosed by a physician and confirmed by other clinical data;
  • Self-reported hospitalization for treatment of heart disease in past 6 months;
  • Impaired renal and liver function, and pancreatitis;
  • Self-reported recent or significant abdominal surgery;
  • Self-reported pregnancy and/or intentional pregnancy during the study;
  • Self-reported hospitalization for stroke or transient ischemic attack episode in the past 6 months;
  • Inability to ensure availability for the next 12 months

研究者

发起方
Rishaal Sharma

相似试验